Details for: JIVI
Company: BAYER INC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02481766 | JIVI | ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED) | 500 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
02481774 | JIVI | ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED) | 1000 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
02481782 | JIVI | ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED) | 2000 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
02481790 | JIVI | ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED) | 3000 UNIT / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
Summary Reports
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
JIVI is for the treatment of hemophilia A in previously treated patients (PTPs) 12 years of age and older. JIVI can be used to:
What it does
When it should not be used
What the medicinal ingredient is
Antihemophilic Factor (Recombinant, B-domain deleted, PEGylated)
What the non-medicinal ingredients are
Calcium chloride, Histidine, Glycine, Polysorbate 80, Sodium chloride, Sucrose
What dosage form it comes in
JIVI is available in single-use vials that contain nominally 250, 500, 1000, 2000, or 3000 International Units (IU) per vial. After reconstitution with the supplied diluent (sterile water for injection), the prepared solution for injection will have the following concentration:
Vial Size | Approximate Concentration After Reconstitution |
---|---|
250 IU | 100 IU/mL |
500 IU | 200 IU/mL |
1000 IU | 400 IU/mL |
2000 IU | 800 IU/mL |
3000 IU | 1200 IU/mL |
Warnings and precautions
Allergic reactions to JIVI have occurred.
If you experience tightness in the chest, feel dizzy, sick or faint, or experience dizziness upon
standing, you may be experiencing a rare severe sudden allergic reaction (a so-called
anaphylactic reaction) to JIVI. If this occurs, stop administration of the product immediately and
seek medical advice.
Your doctor may carry out tests to ensure that your current dose of JIVI provides adequate
Factor VIII levels.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
Interactions with this medication
No interactions with other medicines are known.
Proper use of this medication
JIVI is given by injection into the bloodstream (intravenously).
JIVI should be injected intravenously over a period of 1 to 15 minutes depending on the total
volume. The rate of administration depends on your comfort level. The maximum infusion rate is
2.5 mL/min.
Administer reconstituted JIVI as soon as possible. If not, store at room temperature for no
longer than 3 hours.
You must use aseptic conditions (meaning clean and germ free) during reconstitution and
administration. Use only the medical devices (Vial Adapter, pre-filled syringe containing diluent
and administration set) for reconstitution and administration that are provided with each carton
of JIVI. If a device package is opened or damaged, do not use this medical device. If these
devices cannot be used, please contact your healthcare provider. If you have any questions
about JIVI, contact Bayer at 1-800-265-7382 or canada.medinfo@bayer.com.
JIVI must not be mixed with other medicinal products or solvents. Follow the directions given by
your doctor closely and use the instructions below as a guide:
- Warm both unopened vial and syringe in your hands to a comfortable temperature (do not exceed 37°C, 99°F).
- Remove protective cap from the vial (A). Disinfect the rubber stopper with alcohol, being careful not to handle the rubber stopper.
- Place product vial on a firm, non-skid surface. Peel off the paper cover on the Vial Adapter plastic housing. Do not remove the adapter from the plastic housing. Holding the adapter housing, place over the product vial and firmly press down (B). The adapter will snap over the vial cap. Do not remove the adapter housing at this step.
- Holding the syringe by the barrel, snap the syringe cap off the tip (C). Do not touch the syringe tip with your hand or any surface. Set the syringe aside for further use.
- Now remove and discard the adapter housing (D).
- Attach the pre-filled syringe to the threaded Vial Adapter by turning clockwise (E).
- Grasp the plunger rod by the top plate and remove from carton. Avoid touching the sides and threads of the plunger rod. Immediately attach the plunger rod by turning it firmly clockwise into the threaded syringe rubber stopper (F).
- Inject the diluent by slowly pushing down on the plunger rod (G).
- Swirl vial gently until all material is dissolved (H). Do not shake vial. Be sure that the powder is completely dissolved. Do not use solutions containing visible particles or that are cloudy.
- Push down on the plunger to push all air back into the vial. Then while holding the plunger down, turn the vial with syringe upsidedown (invert) so the vial is now above the syringe (I).
- Withdraw all the solution into the syringe by pulling the plunger rod back slowly and smoothly (J). Tilt the vial to the side and back to make sure all the solution has been drawn toward the large opening in the rubber stopper and into the syringe. Remove as much air as possible before removing the syringe from the vial by slowly and carefully pushing the air back into the vial.
- Detach the syringe with plunger rod from the vial adapter by turning counter-clockwise. Attach the syringe to the administration set provided and inject intravenously (K). NOTE: follow instructions for infusion set provided. The small amount of drug product left in the administration set will not affect your treatment.











Visually inspect the reconstituted JIVI solution for particulate matter and change in colour before administration. JIVI should be clear and colourless. Do not use JIVI if you see particles or if the solution is cloudy.
Documentation
It is recommended that every time you use JIVI, you note down the name and batch number of the product.
Usual dose:
Prevention of bleeding (prophylaxis)
JIVI can be used to increase Factor VIII levels in your body to help prevent bleeding before it happens, and to protect joints.
The recommended initial regimen is 30-40 IU/kg twice weekly. Based on bleeding episodes, the regimen can be adjusted to 45-60 IU/kg every 5 days. A regimen may be further individually adjusted to more or less frequent dosing.
Because everyone is different, your doctor will individualize your JIVI regimen to meet your specific needs. To get the most out of your treatment, be sure to administer JIVI at the dose and frequency prescribed by your doctor.
Treatment of bleeding
How much JIVI you should use and how often you should use it depends on many factors, including your weight, the severity of your hemophilia, where the bleed is and how serious it is, whether you have inhibitors and the level of inhibitors your blood, and the Factor VIII level that is needed.
Your doctor will calculate the dose of JIVI and how frequently you should use it to get the necessary level of Factor VIII activity in your blood. He/she should always adjust the amount of JIVI to be administered and the frequency of administration according to your individual needs. Under certain circumstances larger amounts than those calculated may be required, especially for the initial dose.
Laboratory Test
After treatment, it is strongly recommended that appropriate laboratory tests be performed on your plasma at suitable intervals to ensure that adequate Factor VIII levels have been reached and are maintained. For major surgery in particular, close monitoring of the treatment by means of coagulation analysis must be carried out.
If bleeding is not controlled
If the Factor VIII level in your plasma fails to reach expected levels, or if bleeding is not controlled after adequate dose, you may have developed Factor VIII inhibitors. This must be checked by an experienced doctor.
If you feel the effect of JIVI is too strong or too weak, talk to your doctor. Patients with inhibitors
If you have been told by your doctor that you have developed Factor VIII inhibitors, you may need to use a larger amount of JIVI to control bleeding.
Do not increase your dose of JIVI you use to control your bleeding without consulting your doctor.
Duration of treatment
Your doctor will tell you, how often and at what intervals JIVI is to be administered.
Usually, replacement therapy with JIVI is a life-time treatment. Overdose:
No symptoms of overdose with recombinant human coagulation Factor VIII have been reported.
Missed Dose:
Side effects and what to do about them
As with all medicines, JIVI can cause side effects, although not everybody gets them. Most of
the side effects are mild to moderate. These are not all the possible side effects that you may feel when taking JIVI. If you experience any side effects not listed here, contact your healthcare
professional.
Very common (may affect 10% of patients or more)
Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drug and get immediate medical help |
---|---|---|---|
Common | |||
Hypersensitivity reactions including tightness of the chest/general feeling of being unwell, dizziness and nausea and mildly reduced blood pressure, which may make you feel faint upon standing. | ✔ |
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.
How to store
Do not use beyond the expiration date indicated on the labels and cartons.
Store in a refrigerator (2-8°C). Do not freeze.
Keep the vial and the pre-filled syringe in the outer carton in order to protect from light.
You may store the product when kept in its outer carton at room temperature up to 25°C for 6
months or up to 30°C for 3 months. Once the product is removed from refrigeration, it cannot be
returned to the refrigerator.
If the product is stored outside the refrigerator, please add the date removed from refrigeration
and note a new expiry date on the carton and vial. The new expiry date should be 6 months
(25°C) or 3 months (30°C) from the date product is removed from the refrigerator, or the
previously stamped expiry date, whichever is shorter.
The reconstituted solution should be used immediately (within 3 hours). This product is for
single use only. Any unused solution must be discarded.
Keep out of reach and sight of children.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffectcanada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
If you want more information about JIVI:
This leaflet was prepared by
Bayer Inc.
2920 Matheson Blvd East,
Mississauga, Ontario
L4W 5R6
Canada
Last Revised October 15, 2018
© 2018, Bayer Inc.
® TM see www.bayer/ca/tm-mc